CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia (AML) and the Myelodysplastic Syndromes (MDS)

被引：0
|
作者：
Chung, Stephen S. [1 ]
Devlin, Sean [1 ]
Park, Christopher Y. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷
关键词：
D O I：
10.1016/j.clml.2014.06.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [21] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    David P. Steensma
    Medrdad Abedi
    Rafael Bejar
    Christopher R. Cogle
    Kathryn Foucar
    Guillermo Garcia-Manero
    Tracy I. George
    David Grinblatt
    Rami Komrokji
    Xiaomei Ma
    Jaroslaw Maciejewski
    Daniel A. Pollyea
    Michael R. Savona
    Bart Scott
    Mikkael A. Sekeres
    Michael A. Thompson
    Arlene S. Swern
    Melissa Nifenecker
    Mary M. Sugrue
    Harry Erba
    BMC Cancer, 16
  • [22] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    Steensma, David P.
    Abedi, Medrdad
    Bejar, Rafael
    Cogle, Christopher R.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    George, Tracy I.
    Grinblatt, David
    Komrokji, Rami
    Ma, Xiaomei
    Maciejewski, Jaroslaw
    Pollyea, Daniel A.
    Savona, Michael R.
    Scott, Bart
    Sekeres, Mikkael A.
    Thompson, Michael A.
    Swern, Arlene S.
    Nifenecker, Melissa
    Sugrue, Mary M.
    Erba, Harry
    BMC CANCER, 2016, 16
  • [23] CD99 is a therapeutic target on disease stem cells in myeloid malignancies
    Chung, Stephen S.
    Eng, William S.
    Hu, Wenhuo
    Khalaj, Mona
    Garrett-Bakelman, Francine E.
    Tavakkoli, Montreh
    Levine, Ross L.
    Carroll, Martin
    Klimek, Virginia M.
    Melnick, Ari M.
    Park, Christopher Y.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (374)
  • [24] End of Life (EOL) Metrics in Older Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
    LoCastro, M.
    Baran, A. M.
    Liesveld, J.
    Becker, M. W.
    O'Dwyer, K. M.
    Husehon, E.
    Aljitawi, O. S.
    Baumgart, M.
    Snyder, E.
    Kluger, B.
    Mendler, J. H.
    Loh, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S285 - S285
  • [25] Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    Al-Kali, Aref
    Navada, Shyamala C.
    Baer, Maria R.
    Raza, Azra
    Greenberg, Peter
    Kreuzer, Karl-Anton
    Hiwase, Devendra K.
    Roboz, Gail J.
    Santini, Valeria
    Platzbecker, Uwe
    Petrone, Michael E.
    Brownstein, Bernard
    Zbyszewski, Patrick Simon
    Maniar, Manoj
    Silverman, Lewis R.
    BLOOD, 2016, 128 (22)
  • [26] Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)
    Madanat, Yazan F.
    Sekeres, Mikkael A.
    Mukherjee, Sudipto
    Al-Issa, Karam
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Jha, Babal K.
    Adema, Vera
    Advani, Anjali
    Nagata, Yasunobu
    Kuzmanovic, Teodora
    Carraway, Hetty E.
    Przychodzen, Bartlomiej
    Maciejewski, Jaroslaw P.
    Nazha, Aziz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S261 - S261
  • [27] Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors
    Jonsdottir, Gudbjorg
    Bjorkholm, Magnus
    Turesson, Ingemar
    Hultcrantz, Malin
    Porwit, Anna
    Jethava, Yogesh
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD, 2017, 130
  • [28] Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States
    Albitar, Adam Zrinski
    Shah, Neil
    McCloskey, James K.
    Koprivnikar, Jamie L.
    Zhao, Jianhua
    Desai, Chirag
    Sudarsanam, Sucha
    Albitar, Maher
    Lai, Catherine E.
    BLOOD, 2018, 132
  • [29] How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma, David P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (04)
  • [30] Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)
    Madanat, Yazan F.
    Sekeres, Mikkael A.
    Al-Issa, Karam
    Hirsch, Cassandra M.
    Mukherjee, Sudipto
    Gerds, Aaron T.
    Abuhadra, Nour
    Jha, Babal K.
    Adema, Vera
    Advani, Anjali S.
    Nagata, Yasunobu
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Nazha, Aziz
    BLOOD, 2017, 130
12345